| ‘Off-the-shelf’allogeneic CAR T cells: development and challenges S Depil, P Duchateau, SA Grupp, G Mufti, L Poirot Nature reviews Drug discovery 19 (3), 185-199, 2020 | 858 | 2020 |
| Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies R Benjamin, C Graham, D Yallop, A Jozwik, OC Mirci-Danicar, G Lucchini, ... The Lancet 396 (10266), 1885-1894, 2020 | 276 | 2020 |
| Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label … S Grosicki, M Simonova, I Spicka, L Pour, I Kriachok, M Gavriatopoulou, ... The Lancet 396 (10262), 1563-1573, 2020 | 261 | 2020 |
| Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial MA Dimopoulos, F Gay, F Schjesvold, M Beksac, R Hajek, KC Weisel, ... The Lancet 393 (10168), 253-264, 2019 | 245 | 2019 |
| Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity C Roddie, JPV Paul, R Benjamin, CI Gallimore, J Xerry, JJ Gray, ... Clinical Infectious Diseases 49 (7), 1061-1068, 2009 | 176 | 2009 |
| Allogeneic CAR-T cells: more than ease of access? C Graham, A Jozwik, A Pepper, R Benjamin Cells 7 (10), 155, 2018 | 172 | 2018 |
| Apolipoprotein E genes in Lewy body and Parkinson's disease R Benjamin, A Leake, JA Edwardson, IG McKeith, PG Ince, RH Perry, ... The Lancet 343 (8912), 1565, 1994 | 141 | 1994 |
| LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma MV Mateos, K Weisel, V De Stefano, H Goldschmidt, M Delforge, M Mohty, ... Leukemia 36 (5), 1371-1376, 2022 | 132 | 2022 |
| Poor outcome and prolonged persistence of SARS‐CoV‐2 RNA in COVID‐19 patients with haematological malignancies; King's College Hospital experience V Shah, TK Ko, M Zuckerman, J Vidler, S Sharif, V Mehra, S Gandhi, ... British Journal of Haematology 190 (5), e279, 2020 | 122 | 2020 |
| Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients S Abdul-Jawad, L Baù, T Alaguthurai, IDM Del Barrio, AG Laing, ... Cancer cell 39 (2), 257-275. e6, 2021 | 112 | 2021 |
| Protective effect of apoE epsilon 2 in Alzheimer's disease. R Benjamin, A Leake, FK McArthur, PG Ince, JM Candy, JA Edwardson, ... Lancet (London, England) 344 (8920), 473-473, 1994 | 91 | 1994 |
| Preliminary data on safety, cellular kinetics and anti-leukemic activity of UCART19, an allogeneic anti-CD19 CAR T-cell product, in a pool of adult and pediatric patients with … R Benjamin, C Graham, D Yallop, A Jozwik, O Ciocarlie, N Jain, ... Blood 132, 896, 2018 | 87 | 2018 |
| Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk‐1) following lentiviral‐mediated gene transfer inhibit … CA Kyriakou, KL Yong, R Benjamin, A Pizzey, A Dogan, N Singh, ... The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2006 | 85 | 2006 |
| Coating of adeno‐associated virus with reactive polymers can ablate virus tropism, enable retargeting and provide resistance to neutralising antisera RC Carlisle, R Benjamin, SS Briggs, S Sumner‐Jones, J McIntosh, D Gill, ... The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2008 | 76 | 2008 |
| Tumor-targeted human T cells expressing CD28-based chimeric antigen receptors circumvent CTLA-4 inhibition M Condomines, J Arnason, R Benjamin, G Gunset, J Plotkin, M Sadelain PloS one 10 (6), e0130518, 2015 | 75 | 2015 |
| Molecular biology of APO E alleles in Alzheimer’s and non-Alzheimer’s dementias CM Morris, HM Massey, R Benjamin, A Leake, C Broadbent, M Griffiths, ... New Trends in the Diagnosis and Therapy of Non-Alzheimer’s Dementia, 205-218, 1996 | 75 | 1996 |
| Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations K Rejeski, M Subklewe, M Aljurf, E Bachy, A Balduzzi, P Barba, B Bruno, ... Blood 142 (10), 865-877, 2023 | 70 | 2023 |
| A new xenograft model of myeloma bone disease demonstrating the efficacy of human mesenchymal stem cells expressing osteoprotegerin by lentiviral gene transfer N Rabin, C Kyriakou, L Coulton, OM Gallagher, C Buckle, R Benjamin, ... Leukemia 21 (10), 2181-2191, 2007 | 64 | 2007 |
| Cancer immunotherapy with CAR-T cells–behold the future C Graham, R Hewitson, A Pagliuca, R Benjamin Clinical Medicine 18 (4), 324, 2018 | 63 | 2018 |
| The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia J Delgado, S Pillai, R Benjamin, D Caballero, R Martino, A Nathwani, ... Biology of Blood and Marrow Transplantation 14 (11), 1288-1297, 2008 | 59 | 2008 |
